The TargetScanHuman prediction analysis reported that miR-499a-3p may target TNFSF14, MAPK1, MEF2C, ATF6, MAOA, IL7R, and INPP5D. These findings suggested that miR-499a could be implicated in PD pathophysiology by modulating the expression of its target genes and the associated pathways. This evidence concerns the gene IL7R and Parkinson disease.